Nov 12 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2020 Sep 30, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 240 mln 451 mln 310 mln
(-46.8 pct) (+119.4 pct) (-46.6 pct)
Operating loss 147 mln 107 mln loss 390 mln
Recurring loss 164 mln 99 mln loss 410 mln
Net loss 150 mln 119 mln loss 340 mln
EPS loss 5.70 yen 4.57 yen loss 12.94 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T